swisschems semaglutide FBI issues safety warning about counterfeit versions of weight loss drug Semaglutide: Next Generation Weight Loss

Currently, most GLP-1 medications are patent-protected, which means other companies cannot manufacture them, and there are no competitors

healthcare providers wrote more than 9 million prescriptions for Wegovy, Ozempic, and other GLP-1 agonists in the last three months of 2022 alone

Because these are compounded rather than FDA-approved finished products, they havent undergone the FDAs premarket review for safety, effectiveness, or manufacturing quality

Minimize air exposure

For example, two people can weigh 150 pounds (68 kg) but have completely different body fat and muscle proportions

"Temperature-Dependent Degradation Kinetics of Triple-Agonist Peptide Therapeutics." International Journal of Pharmaceutics , 648, 123567